Search

everythinglearnresearchcommunity

for

Search:↓

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Finasteride capsules with nanoparticles improve drug delivery, solubility, stability, and effectiveness.

PEVs effectively deliver minoxidil through skin.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Using iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles increases drug release but reduces its targeting to hair follicles.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

Copper treatments increase copper in all tissues, but brindled female mice accumulate much more copper in their kidneys without clinical effects, unlike brindled male mice where brain copper deficiency is clinically significant.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Cinnamaldehyde helps bone healing initially but may slow healing later unless combined with DHT treatment.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

A new drug delivery system using oil body-bound oleosin-rhFGF-10 improves wound healing and hair growth in mice.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

A new compound shows promise as a topical treatment for hair loss.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

The method accurately measures the amount of ketoconazole in anti-dandruff shampoo and cream, and can also be used to monitor the drug in human plasma.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Chemical hair straightening significantly reduces detectable drug levels in hair.

A new hydrogel with micronized amnion helps achieve better, scar-free skin healing.

The model and estimator can predict drug exposure in kidney transplant patients well.

Alkylation of human hair keratin allows for adjustable drug release rates in hydrogels for medical use.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Hair follicles can be used to quickly assess drug effects in cancer treatment.